Morgan Stanley Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price objective lowered by research analysts at Morgan Stanley from $136.00 to $110.00 in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price target would indicate a potential upside of 12.58% from the stock’s current price.

A number of other research analysts have also recently weighed in on CLX. Citigroup lowered their price objective on Clorox from $115.00 to $110.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Wells Fargo & Company lowered their price objective on Clorox from $125.00 to $110.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. TD Cowen lifted their price objective on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. The Goldman Sachs Group lowered their price objective on Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research report on Wednesday, January 7th. Finally, Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $111.33.

Clorox Trading Up 0.9%

Shares of NYSE:CLX opened at $97.70 on Wednesday. The stock has a market capitalization of $11.81 billion, a price-to-earnings ratio of 15.96, a PEG ratio of 0.48 and a beta of 0.65. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The stock’s 50-day simple moving average is $110.94 and its two-hundred day simple moving average is $109.62. Clorox has a 52-week low of $96.58 and a 52-week high of $143.96.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm earned $1.55 earnings per share. The firm’s quarterly revenue was down .8% on a year-over-year basis. Analysts expect that Clorox will post 5.88 EPS for the current year.

Institutional Trading of Clorox

A number of large investors have recently added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP increased its stake in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after acquiring an additional 7,465 shares during the last quarter. Baird Financial Group Inc. increased its stake in Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC increased its stake in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia increased its stake in Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after acquiring an additional 3,352 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: IGNITE transformation and cost‑savings initiatives could blunt margin pressure and support recovery if execution holds. Read More.
• Neutral Sentiment: Analysts still expect year‑over‑year EPS growth for the fiscal year, but previews say CLX lacks the setup for a likely earnings beat — growth is expected, but upside surprise looks limited. Read More.
• Negative Sentiment: Previews flag rising costs, soft demand and margin pressure heading into Q3, increasing the risk of an earnings miss that could weigh on the stock. Read More.
• Negative Sentiment: Morgan Stanley cut its price target to $110 and moved to an “equal weight” view, signaling reduced confidence in near‑term upside. Read More.
• Negative Sentiment: Deutsche Bank lowered its price target to $100, adding to downward pressure from broker revisions. Read More.
• Negative Sentiment: Jefferies trimmed its target to $139, and the aggregate analyst consensus has moved toward a “Reduce” stance — a concerning sign that sentiment is deteriorating among brokers. Read More. Read More.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.